Zobrazeno 1 - 10
of 15
pro vyhledávání: '"J R, Zalcberg"'
Publikováno v:
Internal medicine journal. 32(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb2539b15ac3f598c4f89b6bd2bb3835
https://pubmed.ncbi.nlm.nih.gov/12512755
https://pubmed.ncbi.nlm.nih.gov/12512755
Autor:
T, Le Chevalier, J, Bérille, J R, Zalcberg, M J, Millward, A, Monnier, J Y, Douillard, M J, McKeage, R, James, F, Soulas, C, Loret, N, Bougon, J P, Bizzari
Publikováno v:
Seminars in oncology. 26(3 Suppl 11)
Cisplatin-based chemotherapy is effective in non-small cell lung cancer (NSCLC), although it prolongs survival only modestly. Single-agent docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) is highly active against NSCLC. The activity and tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8f2039ad33108cfb712bb81cd5bf677
https://pubmed.ncbi.nlm.nih.gov/10458205
https://pubmed.ncbi.nlm.nih.gov/10458205
Autor:
P, Kantharidis, A, El-Osta, M, deSilva, D M, Wall, X F, Hu, A, Slater, G, Nadalin, J D, Parkin, J R, Zalcberg
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(11)
One of the most important forms of drug resistance in acute myeloid leukemia is the multidrug resistance (MDR) phenotype, which is characterized by the expression of the MDR1 gene product, P-glycoprotein. Although a number of factors affect MDR1 gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bfade59e0fb7a8af3c45a74ddf42debd
https://pubmed.ncbi.nlm.nih.gov/9815593
https://pubmed.ncbi.nlm.nih.gov/9815593
Autor:
J R, Zalcberg
Publikováno v:
The Medical journal of Australia. 166(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1530f9e779cd4fd422b3530b3d12e8bf
https://pubmed.ncbi.nlm.nih.gov/9196492
https://pubmed.ncbi.nlm.nih.gov/9196492
Autor:
D, Cunningham, J R, Zalcberg, U, Rath, I, Olver, E, Van Cutsem, C, Svensson, J F, Seitz, P, Harper, D, Kerr, G, Perez-Manga
Publikováno v:
European journal of cancer (Oxford, England : 1990). (12)
'Tomudex' (ZD1694), a direct and specific thymidylate synthase (TS) inhibitor entered phase III studies in November 1993. We present here the first analysis of a randomised multicentre, international phase III study. 439 patients with previously untr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be3c23332989942ba0194fd16eda2018
https://pubmed.ncbi.nlm.nih.gov/8562146
https://pubmed.ncbi.nlm.nih.gov/8562146
Autor:
J, Siderov, J R, Zalcberg
Publikováno v:
The Medical journal of Australia. 161(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7e3250b99f2bd8ddfd164086d3cf685
https://pubmed.ncbi.nlm.nih.gov/7968747
https://pubmed.ncbi.nlm.nih.gov/7968747
Publikováno v:
Cancer research. 50(10)
This study describes the synergistic interaction of two biochemical modulators, cyclosporin A (CyA) and verapamil (Vp), in multidrug-resistant cells, the highly resistant and moderately resistant variants (CEM/VLB 1000 and CEM/VLB 100) of the parenta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34e29eb2f6a16bc51f2e7abc852ddeea
https://pubmed.ncbi.nlm.nih.gov/1998966
https://pubmed.ncbi.nlm.nih.gov/1998966
Publikováno v:
The Journal of Immunology. 133:1070-1077
By using monoclonal antibodies, a tumor-specific antigen (TSA 41.5) was detected on the cell surface of a B lymphoma CH-1 tumor variant, CH-1.1. This antigen is not expressed by normal lymphocytes (spleen cells, lymph node cells, thymocytes, bone mar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::525d6f87320340ba1fda1904138d874c
https://doi.org/10.4049/jimmunol.133.2.1070
https://doi.org/10.4049/jimmunol.133.2.1070
Publikováno v:
Journal of the National Cancer Institute. 72(3)
This report describes the use of 131I-labeled monoclonal antibodies in two experimental models for tumor immunotherapy. In vitro treatment of the radiation-induced murine thymoma ITT-1-75NS with radiolabeled anti-Ly-2.1 significantly impaired subsequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d24a86f6051cabb8cd1d425c08e25494
https://pubmed.ncbi.nlm.nih.gov/6583453
https://pubmed.ncbi.nlm.nih.gov/6583453
Autor:
J R, Zalcberg, F N, Cornell, H J, Ireton, K M, McGrath, R, McLachlan, R K, Woodruff, J S, Wiley
Publikováno v:
Cancer. 50(3)
A patient with multiple myeloma who subsequently developed chronic lymphocytic leukemia is reported. Initial studies demonstrated clinical and hematological features of multiple myeloma with an IgM lambda paraprotein. Skeletal disease was a significa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::277003655654377d1d16dde5b0ff6f22
https://pubmed.ncbi.nlm.nih.gov/7093901
https://pubmed.ncbi.nlm.nih.gov/7093901